Europe reconsidering DTCA

Meek, Colin
May 2007
CMAJ: Canadian Medical Association Journal;5/8/2007, Vol. 176 Issue 10, p1405
Academic Journal
The article reports that five international associations have joined forces to oppose an anticipated move by the European Commission that would give pharmaceutical companies more freedom to communicate directly with the public. The group claims that pharmaceutical companies have an inherent conflict of interest that renders them unable to provide the information patients need in an unbiased manner.


Related Articles

  • Direct-to-consumer advertising debated in the United States and European Union. Guthrie, Patricia // CMAJ: Canadian Medical Association Journal;5/8/2007, Vol. 176 Issue 10, p1404 

    The article reports that direct-to-consumer (DTC) advertising is being debated in the U.S. and the European Union as Canada assesses the legality of DTC drug advertising in courts. DTC advertising is not allowed in Canada but manufacturers can skirt the law by running ads that either name the...

  • Stage set for Senate to shackle DTC advertisers. Teinowitz, Ira // Advertising Age;2/26/2007, Vol. 78 Issue 9, p43 

    The article states that the U.S. Senate's health committee has set a tentative date to consider legislation from Senator Ted Kennedy of Massachusetts and Senator Michael Enzi of Wyoming that could dramatically restrict direct-to-consumer advertising for prescription drugs. Advertising groups...

  • Effects of Direct-to-Consumer Advertising of Prescription Drugs on Prices. Kalyanaram, Gurumurthy; Phelan, John J. // Journal of Business & Economic Studies;Fall2011, Vol. 17 Issue 2, p67 

    In this paper,we examined the effects of direct-to-consumer advertising (DTCA) of prescription (Rx) drugs on drug prices, price elasticity, and market share. Data on sales, price, and DTCA for three therapeutic classes of Rx drug categories were obtained for the period January 1998 to December...

  • Brussels Sprouts? Pitts, Peter J. // Pharmaceutical Executive;May2006, Vol. 26 Issue 5, p50 

    The article reports on the debate about the restrictive national and European Union laws that make its illegal for pharmaceutical companies to provide any kind of information-to-patients programs (ItP). The author points out to his European colleagues that DTC advertising influences patients to...

  • EC Takes a Second Look at Patient Information. Sheridan, Cormac // BioWorld International;10/12/2011, Vol. 16 Issue 41, p1 

    This article reports on the publication of revised proposals by the European Commission (EC) on the regulation of the flow of information between drugmakers, regulators and patients. The commission placed greater emphasis on consumer and patient rights. The changes will keep the ban on...

  • Shops' DTC disruption roils FDA, Big Pharma. Thomaselli, Rich; Teinowitz, Ira // Advertising Age;4/10/2006, Vol. 77 Issue 15, p16 

    The article reports that the Coalition of Healthcare Communication is asking the U.S. Food and Drug Administration to start over with new rules for the pharmaceutical direct-to-consumer advertising category in 2006. Some drug companies and their trade group, the Pharmaceutical Research and...

  • The Effect of Competing Direct-to-Consumer Advertising Campaigns on the Use of Drugs for Benign Prostatic Hyperplasia: Time Series Analysis. Skeldon, Sean; Kozhimannil, Katy; Majumdar, Sumit; Law, Michael // JGIM: Journal of General Internal Medicine;Apr2015, Vol. 30 Issue 4, p514 

    Background: Direct-to-consumer advertising (DTCA) remains a controversial issue, with concerns that it leads to unnecessary and inappropriate prescribing. Whether DTCA shifts prescribing from first-line (guideline-recommended) therapy to second-line drugs has not been studied. Objective: The...

  • DTC device ads have merit. Hempstead, Susan // Medical Marketing & Media;Jan2006, Vol. 41 Issue 1, p93 

    The article reports that the U.S. Food and Drug Administration (FDA) has sponsored a series of public meetings to solicit information and views about direct-to-consumer (DTC) promotion of prescription drug products through print, broadcast or other types of media. DTC media-product...

  • Turf War Escalates Over Big Pharma Marketing. Edwards, Jim // Brandweek;11/7/2005, Vol. 46 Issue 40, p6 

    This article focuses on the efforts of the U.S. Food and Drug Administration to review policies on direct-to-consumer (DTC) drug advertising as of November 2005. The policies were brought about by the pleas of parties wanting to ban DTC advertising. While no marketer proposed a total advertising...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics